Cargando…

Down-regulation of LAPTM5 in human cancer cells

Lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) is a membrane protein that localizes to intracellular vesicles. It has been previously demonstrated that LAPTM5 expression level is decreased in neuroblastoma (NB) cells, and excessive accumulation of LAPTM5 was shown to induce lyso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuylan, Michelle, Kawano, Tatsuyuki, Inazawa, Johji, Inoue, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053729/ https://www.ncbi.nlm.nih.gov/pubmed/27058622 http://dx.doi.org/10.18632/oncotarget.8614

Ejemplares similares

Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection
por: Okuda, Masafumi, et al.
Publicado: (2017)

Lysosomal-Associated Protein Multispanning Transmembrane 5 Gene (LAPTM5) Is Associated with Spontaneous Regression of Neuroblastomas
por: Inoue, Jun, et al.
Publicado: (2009)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

Ectopic overexpression of LAPTM5 results in lysosomal targeting and induces Mcl-1 down-regulation, Bak activation, and mitochondria-dependent apoptosis in human HeLa cells
por: Jun, Do Youn, et al.
Publicado: (2017)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma
por: Nagata, Hiroaki, et al.
Publicado: (2017)

miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2
por: Harazono, Yosuke, et al.
Publicado: (2013)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells
por: Geng, Yuan-Ming, et al.
Publicado: (2019)

LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr
por: Ouyang, Jiayue, et al.
Publicado: (2022)

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
por: Zhang, Hongtuan, et al.
Publicado: (2015)

Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma
por: Tran, Phuong Xuan, et al.
Publicado: (2022)

Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy
por: Gokita, Kentaro, et al.
Publicado: (2019)

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
por: Berberich, Anne, et al.
Publicado: (2020)

Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment
por: Inoue, Jun, et al.
Publicado: (2020)

Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer
por: Kishikawa, Masahiro, et al.
Publicado: (2021)

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy
por: Li, Tiegang, et al.
Publicado: (2022)

LAPTM5 Plays a Key Role in the Diagnosis and Prognosis of Testicular Germ Cell Tumors
por: Li, Xiunan, et al.
Publicado: (2021)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway
por: Wang, Ying, et al.
Publicado: (2022)

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Zhao, Li, et al.
Publicado: (2021)

LCDR regulates the integrity of lysosomal membrane by hnRNP K–stabilized LAPTM5 transcript and promotes cell survival
por: Yang, Xiwang, et al.
Publicado: (2022)

Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma
por: Inoue, Jun, et al.
Publicado: (2021)

Lysosomal-Associated Transmembrane Protein 5 (LAPTM5) Is a Molecular Partner of CD1e
por: Angénieux, Catherine, et al.
Publicado: (2012)

Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas
por: Dobashi, Yoh, et al.
Publicado: (2015)

Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma
por: Sakha, Sujata, et al.
Publicado: (2016)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway
por: Han, Sijia, et al.
Publicado: (2023)

Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells
por: Liu, Chang, et al.
Publicado: (2021)

LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion
por: Yin, Yanhua, et al.
Publicado: (2021)

Identification and characterization of transforming growth factor beta‐induced in circulating tumor cell subline from pancreatic cancer cell line
por: Sato, Taku, et al.
Publicado: (2018)

Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas
por: Tanimoto, Kousuke, et al.
Publicado: (2019)

Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer
por: Wang, Lu, et al.
Publicado: (2022)

Integrative genome‐wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma
por: Takemoto, Akira, et al.
Publicado: (2021)

Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis
por: Li, Maojin, et al.
Publicado: (2016)

miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
por: Tonouchi, Erina, et al.
Publicado: (2018)

Publisher Correction: miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
por: Tonouchi, Erina, et al.
Publicado: (2018)

Physical Ordering of Three Polymorphic DNA Markers Spanning the Regions Containing a Tumor Suppressor Gene of Renal Cell Carcinoma by Three‐color Fluorescent in situ Hybridization
por: Inazawa, Johji, et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_lr82qnvoo75e1hqn8u47uos44b